Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Impaired Myocardial Fatty Acid Metabolism and Insulin Resistance for Cardiac Death of Hemodialysis Patients With Normal Coronary Arteries

NCT01068080 is registered in ClinicalTrials.gov with Toujinkai Hospital as lead sponsor.

NCT NCT01068080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01068080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Impaired Myocardial Fatty Acid Metabolism and Insulin Resistance for Cardiac Death of Hemodialysis Patients With Normal Coronary Arteries
Lead sponsor
Toujinkai Hospital
Phase
Observational
Overall status
Completed
Start date
January 31, 2001
Completion date
December 31, 2004
Enrollment
155 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, hemodialysis, kidney disease